A recent federal court decision highlights the delicate balance between U.S. Food and Drug Administration (FDA) guidance and trade dress protections for drugs administered in a tablet or capsule form. Last month, a district court issued a preliminary injunction against a competing generic to the cardiovascular drug Entresto, after finding that the generic pill’s size, shape, and color were likely to violate Entrestro’s trade dress….
By: Troutman Pepper Locke
By: Troutman Pepper Locke
